BGMS Bio Green Med Solution, Inc.: institutional ownership and insider trading
8 funds reported holding $93.1K of Bio Green Med Solution, Inc. in their latest 13F filings; in Q2 2026 funds net sold $14.8K, with 1 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $1.62M on the open market.
BGMS revenue and earnings
- Quarter ended Jun 30, 2026: revenue $336K, net income −$405K
- Quarter ended Mar 31, 2026: revenue $743K, net income −$197K
- Quarter ended Dec 31, 2025: revenue n/a, net income −$611K, EPS -4.16
- Quarter ended Sep 30, 2025: revenue $81.0K, net income −$988K, EPS -1.31
Famous investors holding BGMS
- Ken Griffin (Citadel Advisors): $68.5K, 0.0% of the portfolio
Largest institutional holders of BGMS
- CITADEL ADVISORS LLC — $68.5K
- JANE STREET GROUP, LLC — $14.8K
- Tower Research Capital LLC (TRC) — $5.21K
- UBS Group AG (UBS) — $3.94K
- SBI Securities Co., Ltd. — $644
- Root Financial Partners, LLC — $6
- Archer Investment Corp — $1
- OSAIC HOLDINGS, INC. — $0
Recent BGMS insider trades
- Nov 5, 2025: Yap Kim Choy sold 28,540 shares ($48.5K)
- Oct 30, 2025: Ong Yee Lung sold 248,814 shares ($448K)
- Oct 30, 2025: Kua Khai Loon sold 242,477 shares ($436K)
- Oct 30, 2025: Yap Kim Choy sold 112,260 shares ($203K)
5%+ owners
- Doris Wong Sing Ee: 20.6% (Schedule 13D/A, filed Nov 13, 2025)